title: Ultrasound imaging of pseudomyxoma peritonei with numerous vesicles in ascitic fluid.
authors.forename: H
authors.initials: H
authors.lastname: Matsumi
authors.forename: S
authors.initials: S
authors.lastname: Kozuma
authors.forename: Y
authors.initials: Y
authors.lastname: Osuga
authors.forename: T
authors.initials: T
authors.lastname: Yano
authors.forename: H
authors.initials: H
authors.lastname: Yoshikawa
authors.forename: O
authors.initials: O
authors.lastname: Tsutsumi
authors.forename: Y
authors.initials: Y
authors.lastname: Taketani
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000628:therapy; D014408:Biomarkers, Tumor / Q000032:analysis; D018394:CA-125 Antigen / Q000032:analysis; D018395:CA-19-9 Antigen / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D010537:Peritoneum / Q000601:surgery; D011553:Pseudomyxoma Peritonei / Q000175:diagnosis* / Q000628:therapy; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen